Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05544955 · ClinicalTrials.gov registry record · NA
Protein Ingestion Timing on Body Composition and Biochemical Markers in Resistance-trained Males
A NA study of Physical Performance and Hypertrophy, sponsored by Marymount University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05544955: Completed NA study of Physical Performance and Hypertrophy, sponsored by Marymount University.
NCT05544955 is a NA study of Physical Performance and Hypertrophy that has completed, run by Marymount University. The registered enrollment target is 40 participants, below the 3,603-participant average among 6 other Physical Performance trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05544955, a NA study of Physical Performance and Hypertrophy, has completed, sponsored by Marymount University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Protein ingestion timing is an important component for muscle accretion. The investigators hypothesized that protein ingestion timing could affect muscular adaptations and performance in resistance-trained men.
Primary Outcome
Total Lean mass, fat mass, and estimated VAT (g) will be assessed using whole-body DXA
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT isolate whey protein prior to and immediately after resistance training
- DIETARY_SUPPLEMENT isolate whey protein 3 hours prior to and 3 hours after resistance training
Study Locations (1)
Virginia
- Marymount University - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-17 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT05544955 record still lists
NCT05544955 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,603-participant average among 6 other Physical Performance trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Physical Performance appearing as the primary indexed condition, and to 2 interventions - of which isolate whey protein prior to and immediately after resistance training is the first listed.
NCT05544955 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05544955 about?
NCT05544955 is a clinical study titled "Protein Ingestion Timing on Body Composition and Biochemical Markers in Resistance-trained Males". Protein ingestion timing is an important component for muscle accretion. The investigators hypothesized that protein ingestion timing could affect muscular adaptations and performance in resistance-trained men.
What is the current status of trial NCT05544955?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-17. Estimated completion is 2022-12-31.
What conditions does trial NCT05544955 study?
This clinical trial studies the following conditions: Physical Performance, Hypertrophy.
What interventions are being tested in trial NCT05544955?
The interventions under investigation include: isolate whey protein prior to and immediately after resistance training (DIETARY_SUPPLEMENT), isolate whey protein 3 hours prior to and 3 hours after resistance training (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05544955?
This trial is sponsored by Marymount University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05544955 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Performance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COcoa Supplement and Multivitamin Outcomes Study: Effects on Falls and Physical Performance
ACTIVE NOT RECRUITING · NA
-
Dose Effect of a Plant Extract on Fatigue
COMPLETED · NA
-
The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition
COMPLETED · NA
-
Characteristics of Performance in Collegiate Cheerleaders and Dancers
RECRUITING
-
Body Composition and Lifestyle Factors in ROTC
RECRUITING
-
Impact of Erythropoietin on Hematological Adaptations and Physical Performance
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI